Gene Therapies For Rare Diseases Market Insights Video
According to Cognitive Market Research, the global Gene Therapies For Rare Diseases market size is USD 25.6 million in 2024. It will expand at a compound annual growth rate (CAGR) of 26.80% from 2024 to 2031.
North America held the major market share for more than 40% of the global revenue with a market size of USD 10.24 million in 2024 and will grow at a compound annual growth rate (CAGR) of 25.00% from 2024 to 2031.
Europe accounted for a market share of over 30% of the global revenue with a market size of USD 7.68 million.
Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 5.89 million in 2024 and will grow at a compound annual growth rate (CAGR) of 28.8% from 2024 to 2031.
Latin America had a market share for more than 5% of the global revenue with a market size of USD 1.28 million in 2024 and will grow at a compound annual growth rate (CAGR) of 26.2% from 2024 to 2031.
Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 0.51 million in 2024 and will grow at a compound annual growth rate (CAGR) of 26.5% from 2024 to 2031.
The Approved Drugs held the highest Gene Therapies For Rare Diseases market revenue share in 2024.
